logo
From an Intern Doctor's Suicide to Infant Kidney Transplant: Unveiling China's Organ Harvesting Industry

From an Intern Doctor's Suicide to Infant Kidney Transplant: Unveiling China's Organ Harvesting Industry

Epoch Times15 hours ago
The Chinese Communist Party's (CCP's) forced organ harvesting practices, once primarily targeting Falun Gong practitioners, have escalated into a broader societal issue with alarming international implications.
Huang Shiwei, vice chairman of the medical ethics nonprofit Taiwan International Organ Transplant Care Association, spoke on NTD's Health 1+1 program, saying that recent revelations surrounding the suspicious suicide of an intern doctor and the use of infants' kidneys for transplant have cast a stark light on how the CCP runs its illicit organ transplant industry.
'Donor Search' at Chinese Hospitals
A chilling revelation has emerged from the Second Xiangya Hospital of Central South University, where internal documents and audio recordings, made public by the father of the late medical intern Luo Shuaiyu on June 17, expose a systematic practice of illicit organ sourcing within Chinese hospitals.
Luo, a graduate student specializing in kidney transplantation, fell to his death from a building in May 2024, just weeks before his graduation.
After his death, his family discovered a trove of evidence on his computer implicating the Second Xiangya Hospital in illegal organ trafficking. His father, posting on Weibo, said that Luo refused to comply with hospital directives to source organs of untraceable origin, a stance that may have led to his death.
The Luo case, according to Huang, is indicative of a broader, troubling trend in Chinese medical institutions.
'Every hospital is searching for organs,' Huang said, 'They asked [Luo] to find child donors. Where was he supposed to look? Among the children being treated at the hospital, he was tasked with identifying suitable donors.'
Huang said Luo's refusal to participate in this ethically fraught practice led to intense pressure, culminating in his tragic death.
Luo's parents released three audio recordings that reveal the hospital's efforts to source child donors for transplantation and research. One recording details a directive for Luo to locate 12 child donors aged 3 to 9. According to his parents, Luo was pressured to fulfill this task in the months leading up to his graduation, with his academic grades and degree at risk if he failed to comply.
Facing suppression online, Luo's parents continue to seek justice, raising global awareness of the hospital's alleged involvement in illegal organ trafficking and coercive tactics to enforce compliance among medical staff.
Infant Kidneys Targeted
On May 21, 2024, Fudan University Medical College in Shanghai established a pediatric organ transplant center. While the hospital emphasized that the center was created to save sick children, Chinese parents increasingly fear that their loved ones are becoming targets for organ harvesting.
According to the university, Li Qian, CCP secretary at the pediatric hospital, claimed that 'in just over a year, [pediatric organ transplants] have exceeded 100 cases.' State media outlet Sina reported that the hospital has performed highly complex surgeries, including kidney transplants from donors weighing less than 5 kg (11 pounds), indicating that newborns are among the donors.
The practice of transplanting children's kidneys into adults has become routine in Chinese hospitals. In 2017, the First Affiliated Hospital of Sun Yat-sen University in Guangzhou reported that 90 percent of pediatric kidney donors were allocated to adult patients.
A 2023 study by doctors from Shanghai Jiao Tong University's Renji Hospital, published in the American Journal of Transplantation, detailed two cases of kidney transplants from newborns born at 29 weeks and 29 weeks, 5 days to adult women aged 34 and 25 with end-stage kidney disease. The kidneys were harvested on the second and third days after birth, prompting ethical scrutiny.
Shabih Manzar, associate professor of clinical pediatrics at Louisiana State University, questioned the procedure in the same journal, noting that one of the 29-week preterm infants had no apparent life-threatening conditions, casting doubt on the decision to withdraw life-sustaining treatment.
Huang noted the high survival rates of 29-week preterm infants with modern medical technology.
'Whether it's the parents or the medical system, everyone would typically do everything possible to save these preterm newborns,' he said. 'No one would give up and simply designate them as organ donors. Yet, we see that they are using 29-week preterm infants as organ donors.'
China's Organ Harvesting Industry
2000–2006: Explosive Growth in Organ Transplants Following CCP's Persecution of Falun Gong
China's organ transplant industry, which began using organs from executed prisoners—including political prisoners and prisoners of conscience—following a 1984 regulation allowing organ procurement from executed prisoners, saw explosive growth after the CCP's persecution of Falun Gong began in 1999.
Huang noted that after former CCP leader Jiang Zemin initiated the persecution campaign against Falun Gong, practitioners were branded as 'class enemies,' making them prime targets for forced organ harvesting.
This period marked an unprecedented surge in organ transplants. According to data from the World Organization to Investigate the Persecution of Falun Gong, compiled from Chinese state media reports, only 135 liver transplants were recorded in China over more than two decades before 1999, averaging five to six cases annually. In stark contrast, from 1999 to 2006, liver transplants skyrocketed to 14,085 cases over eight years, averaging more than 1,700 cases per year—a staggering 180-fold increase.
'Organ transplantation in China suddenly became a massive industry,' Huang said. 'With countless patients in China and worldwide needing organs, there are enormous commercial interests at play.'
2007: A Fault Line in Organ Shortage
In March 2006, a whistleblower using the pseudonym Annie, a former employee of Sujiatun Thrombosis Hospital in Shenyang, Liaoning Province, revealed to The Epoch Times the CCP's horrific practice of forced organ harvesting from Falun Gong practitioners. This exposure had a significant impact on China's organ transplant industry.
According to the China Liver Transplant Registry, cited by state media People's Daily, liver transplants peaked at 2,970 cases in 2005 and 2,781 in 2006 but fell by roughly one-third to 1,822 cases in 2007.
Huang attributed this decline to the 2006 revelations.
'The reason for the decrease in organ transplants in China in 2007 was the exposure of the CCP's forced organ harvesting from Falun Gong practitioners,' Huang said.
'As relatives relentlessly searched for family members detained for practicing Falun Gong, it became increasingly difficult for the CCP's public security and medical personnel to continue using Falun Gong practitioners' organs on such a large scale.'
He said the drop in transplant numbers underscores the international scrutiny and domestic pressure that began to disrupt the CCP's organ harvesting operations.
Expansion to More Victims
Facing international scrutiny and domestic pressure over its forced organ harvesting from Falun Gong practitioners, China's organ harvesting industry began targeting other vulnerable groups, including Uyghurs, and other ethnic groups, as well as young people, children, and infants.
Huang said: 'In most countries, organ donors tend to be older, 50, 60, or even 70 years old. But in China, the organ transplant industry operates differently. When organs are supplied to wealthy individuals, they naturally demand those from younger people. The focus has shifted to young individuals and, increasingly, to children.'
Recent years have seen a surge in mysterious disappearances of adolescents across multiple Chinese provinces. Despite China's extensive surveillance infrastructure—boasting the world's largest network of monitoring cameras, big data analytics, and facial recognition technology—these incidents remain unresolved, fueling public suspicion of forced organ harvesting.
In October 2022, Hu Xinyu, a first-year high school student in eastern China's Jiangxi Province, mysteriously disappeared from school. Various reports from insiders and overseas whistleblowers allege that the Hu case is linked to forced organ harvesting, a practice purportedly known within the local government. These claims suggest the existence of an organ trafficking network involving government officials, hospitals, and public security entities.
In August 2023, 8-year-old Wang Sijun, who had a rare Rh-negative blood type, died unexpectedly while receiving treatment at Yunnan Red Cross Hospital.
According to viral videos posted by her family on platforms such as Douyin, Wang was admitted for a routine examination while accompanying a relative, only to die in the nephrology ward. Her autopsy cited hemorrhagic shock as the cause of death, with traces of the anticoagulant enoxaparin sodium detected, leading her family to suspect blood extraction and organ theft.
Although no definitive evidence confirms organ harvesting in the case, Huang noted that widespread allegations of hospitals engaging in such practices have created a climate of heightened anxiety.
Documented cases, such as a fraudulent organ donation scandal in Anhui Province's Bengbu City, lend credence to these concerns. Between 2017 and 2018, six defendants, including four doctors, were convicted of deceiving families and illegally harvesting organs from at least 11 patients.
Huang said: 'China's organ transplant industry, driven by the Communist Party's ideology, has evolved into a vast commercial enterprise. These cases show it has become an unregulated beast, with rampant, unchecked organ harvesting.'
He further noted that the industry's expansion to new victim groups highlights a deepening ethical crisis in China's transplant system, raising critical concerns about oversight and accountability.
US Legislative Efforts to Counter Forced Organ Harvesting
As global awareness of forced organ harvesting grows, the United States is taking decisive steps to address the issue through robust legislation.
On May 7, the House of Representatives overwhelmingly passed the Stop Forced Organ Harvesting Act of 2025 with a bipartisan vote of 406–1. The bill targets individuals involved in forced organ harvesting, imposing severe penalties such as asset freezes, financial transaction bans, and visa revocations. Currently, the legislation awaits a Senate vote.
During a House Foreign Affairs Committee hearing on May 21, Rep. Chris Smith (R-N.J.) urged Senate support for the bill. In response, Secretary of State Marco Rubio called forced organ harvesting concerning and pledged to advocate for the legislation's passage in the Senate.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Does acupressure help you sleep better? I asked two experts — this is what they said
Does acupressure help you sleep better? I asked two experts — this is what they said

Tom's Guide

timean hour ago

  • Tom's Guide

Does acupressure help you sleep better? I asked two experts — this is what they said

In a time where we're bombarded with social media trends for sleep like April Theory and the 'sleepy girl mocktail,' it can be easy to forget that there are some methods you can use to help with your slumber that have been around for thousands of years. Like acupressure, a non-invasive, ancient traditional Chinese medicine practice that involves the use of pressure on the face and body at certain points, some of which are used to help with sleep. Research has shown that acupressure can help with sleep, from reducing insomnia, to improving sleep quality in hospital patients and even contributing to better sleep in menopausal women. Here, we'll explore this research and the potential benefits of acupressure for sleep, as well as speaking to experts in the field to find out about what acupressure is, and how you can even practice it in the comfort of your own home. "Acupressure is a non-invasive traditional Chinese medicine technique that uses pressure on the face and body at specific points known as acupoints," says registered acupuncturist Lily Lai, who has a PhD in Chinese Medicine in Primary Care and offers acupressure at her UK clinic. "Pressure is applied in a variety of ways – most commonly finger pressure is used as well as tools," she adds. Doctor of Oriental Medicine (DOM), Dr. Haley Parker, who is a licensed acupuncturist and the Director of Clinical Operations at VUIM Clinic (Virginia University of Integrative Medicine), explains that in acupressure, gentle sustained pressure is applied to "specific points along the body's meridians — energy channels that correspond to organs and systems." Get instant access to breaking news, the hottest reviews, great deals and helpful tips. "It's based on the same principles as acupuncture, but instead of using needles, you use fingers, palms, elbows, or tools to stimulate the points," Dr. Parker explains. "The idea is to restore the smooth flow of Qi (vital energy) and blood through the body to promote healing, reduce tension, and support balance between the body and mind," she says. "From a Western perspective, acupressure may stimulate the nervous system, influence endorphin release, reduce cortisol, and activate the parasympathetic 'rest and digest' response," the doctor continues. According to The American Institute of Alternative Medicine, the practice is "based on the belief that applying firm pressure in specific acupoints stimulates the nervous system and brain to release endorphins and neurotransmitters to ease... pain." Acupressure falls under what the National Health Service (NHS) in the UK describes as 'complimentary and alternative medicine' (CAM) and they do advise that "if you think you may have a health condition, first see your GP. Do not visit a CAM practitioner instead of seeing your GP." As the NHS points out, it is important to review the evidence when considering a complimentary or alternative medicine. When it comes to acupressure there is "a growing body of evidence supporting [its] effectiveness for sleep," says Dr. Parker. As well as the research cited below, a review of studies into the effect of acupressure on hospital inpatients showed that it improved factors such as sleep quality, total sleep time, sleep efficiency and sleep onset latency compared to control groups. Researchers concluded that it is an "effective intervention to improve sleep quality and sleep parameters in inpatients." Among the studies she highlighted, Dr. Parker pointed to a review of studies and a specific study which both showed that acupressure improved sleep quality in older people. As we've explored above, this traditional Chinese medicine practice involves applying pressure to certain points. Dr. Parker says it can support sleep "by calming the nervous system, easing physical tension, and regulating the underlying organ systems that influence rest." She notes that the best combination of acupressure points for sleep depends on what the individual is experiencing and that a personal point prescription would then be selected to "to support the patient and the present symptoms, like insomnia and restlessness." However, she shares the following common points and how they work from a traditional Chinese medicine perspective: Anxiety can mean that worries, racing thoughts and restlessness make it particularly hard to fall asleep. Lai says that one of the common causes of sleeplessness is stress and anxiety, and points to a systematic review and meta-analysis of research which showed acupressure can significantly reduce anxiety. Acupressure can significantly reduce anxiety "Studies suggest that acupressure and acupuncture work in similar ways by encouraging the body to release neurotransmitters such as endorphins and serotonin," says Dr. Parker. "both of which are mood elevators and play a major role in sleepregulation via the hypothalamic-pituitary-adrenal (HPA) axis," she explains. "Acupressure may also be increasing parasympathetic nervous activity, the rest-and-digest part of our nervous system which takes the body away from being in the sympathetic nervous system state, the fight-or-flight response," Lai adds. She says that these calming, anxiety-reducing effects of acupressure can help sleep by improving both sleep latency, and sleep duration. Those who have experienced either short-term (several days or weeks) or chronic insomnia (lasting three months or more), know that it doesn't just interfere with your sleep. It can also cause issues including irritability, fatigue and problems with focus the next day. But research shows that acupressure may be a tool you can include to combat it. One study compared the effect of acupressure on those with insomnia, with 200 participants divided into a group who were taught self-administered acupressure, and a group who were given sleep hygiene education. They found that those who had learned acupressure had improved Insomnia Severity Index scores after both four weeks and eight weeks, compared to the other group. Auricular acupressure, which focuses on pressure points on the ear, has been shown in a number of studies to help with insomnia. One review of studies looking at how effective auricular acupressure is as a treatment for insomnia concluded that, "the effects of auricular acupressure on insomnia are comparable to those of estazolam," which is a medication used short-term for treating insomnia. And while Dr. Parker noted above that acupressure be used to help with sleep issues like insomnia, she also explains that, "lack of sleep/insomnia is often a symptom of an underlying imbalance." "There are also lifestyle factors and habits that should be addressed to support a restful nights sleep (examples include limiting screen time before bed, limit caffeine after 3pm in the afternoon, eliminate noises and lights in the bedroom, try to go to bed at a regular time each night etc)," she explains. "Sleep problems can also be associated with hormonal changes and studies have demonstrated that acupressure can be effective for improving sleep in these patient populations," says Lai. A huge number of women experiencing menopause have issues with their sleep. In fact, 2023 research noted that across the world, sleep and menopause effects the lives of about a third of women. Lai suggests that acupressure may be one way to help tackle this, explaining that, "acupressure has shown in recent trials to significantly improve sleep quality in menopausal women." A trial published in the Iranian Journal of Medical Sciences, found that "acupressure alone can improve sleep quality at a rate of 22% in menopausal women by massage on the effective points," and concluded that it "can be used as a complementary treatment to relieve sleep disorders in menopausal women." In addition, Lai says that "Studies have indicated that acupressure impacts hormone-related sleep problems through decreasing levels of follicle stimulating hormone (FSH) as well as through increasing levels of oestradiol." "These in turn improve sleep quality related to hormonal conditions, but also in other symptoms such as hot flushes and fatigue," she explains. If you're interested in exploring acupressure and want some simple options that you can try out from the ease of your home, Dr. Parker suggests the following. Acupressure mats like the Shakti mat and Pranamat have become popular options to try at home, and both promise to help improve your sleep after just 20 minutes use. Pranamat even cites stats from Dr. Marek Dvořák's sleep tracker, which show that after using the Pranamat 20 minutes before sleep, his REM sleep increased by 2%, deep sleep increased by 7% and light sleep was reduced by 10%. Lai also shares the one piece of advice given to every patient in her practice experiencing sleep issues: "Utilise acupressure wristbands to stimulate Nei Guan (Pericardium 6). Whilst this acupoint is widely known for nausea and vomiting, it is also used frequently in traditional acupuncture for sleeplessness as well as for stress and anxiety," she says. This pressure point is found between the two tendons ont he inner aspect of the forearm, three finger widths below the wrist crease. It's important to consult your doctor if you are experiencing pain or a medical condition, however, Lai and Dr. Parker agree that acupressure is, in general, very safe for most people. "Basic self-acupressure can be safely carried out in specific circumstances such as with acupressure wristbands for nausea and vomiting," Lai says. But she notes that, "for face, body or ear acupuncture and for more complex conditions, this is safest and most effective when carried out by a TCM practitioner who is registered with an appropriate acupuncture professional body." "If you are actively under the care of a doctor or consultant for a medical condition, you should always seek their advice prior to using acupressure," she explains. It's important that certain patient groups such as children, pregnant women and the elderly should check with their doctor before using acupressure for their health concerns.

Attacks in China and Japan raise concerns about xenophobia in both countries

time9 hours ago

Attacks in China and Japan raise concerns about xenophobia in both countries

A Japanese woman living in China was attacked and injured by a man in a Suzhou subway station, Japanese media outlets said, hours after two Chinese men were seriously injured in violence in Tokyo. The attacks on Thursday raised concern about xenophobic sentiment in both China and Japan that have been blamed for assaults in both countries. It was the third attack involving Japanese living in China since last year. In the two previous cases in China, Chinese authorities have insisted they were isolated incidents. The Japanese broadcaster NHK did not identify the woman injured in Suzhou by name but, citing the Japanese Consulate General in Shanghai, said she was with her child inside a subway station when the attack took place. The child was not injured, and the mother had returned home after reportedly getting treated at a hospital, NHK reported. A phone call to the Suzhou Police went unanswered on Friday evening, and the local police were yet to release any official statement. But the Japanese news agency Kyodo said the suspect had been detained. In Tokyo earlier Thursday, two Chinese men were seriously injured in attacks, and four male assailants wielding unspecified weapons remained at large, according to a statement released by the Chinese Embassy in Japan. The identities of the assailants were unclear. The Chinese Embassy urged the Japanese authorities to take action to catch the assailants in the Tokyo attack and to ensure the safety and legal rights of Chinese citizens in Japan 'in response to the recent surge in xenophobic sentiment in Japanese society.' In southern China last September, a 10-year-old Japanese student died after being stabbed by a Chinese man not far from the gate of the Shenzhen Japanese School in the southern Chinese city of Shenzhen. The man was sentenced to death. In June 2024, a Japanese woman and her child were injured in an attack by a Chinese man, also in Suzhou. A Chinese bus attendant who tried to protect them from the attack was killed. The man was sentenced to death. On Friday, the Japanese Chamber of Commerce and Industry in China called for Chinese authorities to ensure Japanese citizens' safety and security in China. 'It is extremely regrettable that such an incident has happened again. Ensuring the safety of employees and their families is fundamental for doing business in China,' the statement said.

Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic
Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic

Newsweek

time10 hours ago

  • Newsweek

Medicare Update: Trump Admin Launching Pilot Program to Cover Ozempic

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Trump administration is preparing a five-year pilot program that would allow Medicare and Medicaid to cover some of the most in-demand weight-loss drugs, a move that could transform obesity treatment for millions of Americans. The plan, which includes medications such as Ozempic, Wegovy, Mounjaro and Zepbound, represents a reversal in federal policy and signals a broader willingness to use public insurance to address the nation's obesity epidemic. Why It Matters The drugs, known as GLP-1 receptor agonists, were initially developed to treat Type 2 diabetes but have become a cultural phenomenon for their ability to suppress appetite and help patients lose as much as 20 percent of their body weight in clinical trials. The pilot builds on a proposal introduced in the final months of the Biden administration but shelved earlier this year when officials under President Donald Trump announced Medicare and Medicaid would not cover weight-loss medications. What To Know According to documents obtained by The Washington Post, the program would allow state Medicaid programs and Medicare Part D plans to voluntarily cover GLP-1 drugs for weight management. The initiative is scheduled to begin in April 2026 for Medicaid and January 2027 for Medicare and will be administered through the Center for Medicare and Medicaid Innovation, which tests new payment models designed to reduce costs and improve care. Chiquita Brooks-LaSure, who led the Centers for Medicare and Medicaid Services under former President Joe Biden, told the Post the experiment would be a "game changer" if it expands access to obesity treatments. "Increased coverage of anti-obesity medications in Medicare and Medicaid was a priority during my tenure because scientists and clinicians increasingly believe obesity is a serious health condition that should be treated accordingly," she said. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. A pharmacy owner displays an Ozempic package in Pristina, Kosovo, on March 27. Photo by ARMEND NIMANI/AFP via Getty Images The program faces a major hurdle: price. GLP-1 drugs typically cost from $5,000 to $7,000 a year, raising questions about whether widespread coverage is sustainable. "The short-term cost is still huge," Dr. Cynthia Cox, vice president at KFF (formerly Kaiser Family Foundation), told Newsweek. "$1,000 a month per person is a massive outlay." A KFF analysis found that Ozempic's U.S. list price is $936 a month—more than five times the cost in Japan, where it sells for $169. Wegovy, which contains the same active ingredient, costs roughly $1,349 a month in the U.S., compared to $328 in Germany. At the moment, 13 state Medicaid programs cover GLP-1 drugs for obesity. Medicare limits coverage to patients with related conditions such as diabetes or heart disease. With about 70 million people enrolled in Medicaid and 65 million in Medicare, even partial expansion could affect a significant share of the population. Ethicists warn of the potential economic fallout. "These drugs help over 50 percent of people lose up to 25 percent of their body weight," said Dr. Robert Klitzman, a Columbia University bioethicist, in an interview with Newsweek. "But they cost around $12,000 a year. If two-thirds of Americans needed them, it would bankrupt the health care system." Despite the financial concerns, GLP-1 medications are generating enthusiasm among doctors for their ability to improve multiple health markers beyond weight loss. Clinical trials show they can reduce blood sugar, lower blood pressure and improve cardiovascular outcomes. "Ozempic and other GLP-1 drugs are changing how we approach obesity, both in the doctor's office and for society in general," Dr. Raj Dasgupta, chief medical adviser for Garage Gym Reviews, told Newsweek. "They're helping shift the conversation from 'this is a personal failure' to 'this is a medical condition that deserves real treatment.'" The Congressional Budget Office estimates that adding obesity coverage could cost Medicare $35 billion from 2026 to 2034. What People Are Saying A spokesperson for Novo Nordisk, which manufactures Ozempic and Wegovy, told The Washington Post: "We believe that comprehensive coverage through government and commercial insurance plans is critical to affordable health care and treatment options." Klitzman also said in the interview with Newsweek: "Insurance doesn't always cover it, especially for people who don't have diabetes or heart disease. Initially, the drugs were approved for diabetes-related obesity, but doctors have been prescribing them to people who are just overweight, without those conditions." What Happens Next With more than 100 million U.S. adults classified as obese and 22 million considered severely obese, according to the Centers for Disease Control and Prevention, the program's potential impact is vast. The proposal is not final and could undergo a formal public comment period before implementation.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store